This work was undertaken in order to study the effect of nitroglycerin on (a) the cardiac functions in patients with a fixed ventricular rate due to complete heart block and in patients with normal sinus rhythm, and (b) the contribution of atrial systole to ventricular filling at a fixed ventricular rate.
computer* (Model 130), and the cardiac output derived from the area calculated by the computer (Benchimol, Akre, and Dimond, 1965a) .
The pacemaker rate was fixed at a range of the " optimum rate" of pacing as defined in our previous studies (Benchimol, Li, and Dimond, 1964a; Benchimol, Wu, and Liggett, 1965b) , which was between 60 and 80 impulses per minute with an average for the group of 73 beats/min. Three to five determinations of all parameters were obtained, averaged, and designated as control. The patients were then given one tablet of 0-4 mg. of nitroglycerin sublingually and the parameters measured at 1, 2, 4, 6, 10, 15, 20, and 30 minutes after the administration of the drug.
The ventricular rate was measured using lead II of the electrocardiogram simultaneously recorded with the dye-dilution computer.
Arterial pressures were recorded with a P23Db Statham transducer. Mean pressures were obtained by electronic filtering. The rate of change in the brachial artery pressure, i.e. dp/dt, was obtaified in 3 patients by means of an R-C differentiating circuit. Peripheral resistance, average ventricular power, and stroke power were calculated from previously described formulh (Gorlin et al., 1951) . Peak systolic pressure was used in Sarnoff's formula for calculation of the tension-time index (Samoff et al., 1958a) . Ejection time was derived from the indirect carotid tracing recorded at a paper speed of 200 mm./sec. with 20 msec. time lines (Benchimol, Dimond, and Shen, 1960) . The ejection time was corrected for the heart rate in the group with variable ventricular rate, according to Weissler's formula (Weissler et al., 1964) . Mechanical systole was calculated from a medium frequency (40 to 200 cycles/second) phonocardiogram recorded at the mitral area, using a high impedance Cambridge crystal microphone in held expiration. Mechanical systole minus ejection time was taken as isometric contraction time.
Ejection time, mechanical systole, isometric contraction time, arterial pressures, peak derivative of arterial pressure, tension-time index, and mean systolic ejection rate were analysed as functions of the P-R interval (Benchimol et al., 1965c ) before and after nitroglycerin as follows: (a) P occurring during ventricular systole (PS); (b) P-R interval from 1 to 300 msec.; (c) P-R interval from 301 to 500 msec. The values obtained for P waves occurring during ventricular systole were taken as the control figures. The data were analysed statistically and the p values obtained for the differences.
RESULTS
Group 1. Fourteen patients with, complete heart block and with a fixed ventricular rate were studied.
Cardiac Index: The cardiac index did not change significantly after the administration of nitroglycerin. The average control figure was 2 57 l./min./m.2 as compared with 2 52 l./min./m.2 obtained during the fourth minute after the administration of nitroglycerin ( Fig. 1 and 2 ). The mean of the difference was 0.008±01 1 ./min./m2 (p<0-05)t.
Stroke Index: Since the heart rate was fixed the changes in the stroke index paralleled the ones obtained for the cardiac index ( Fig. 1 and 2) .
Central Blood Volume Index: This parameter was measured in 7 patients. Nitroglycerin induced a decrease in this parameter in 3 patients. In the remaining 4 no significant changes were observed. The average central blood volume index in the control figures was 0 91 1./M.2 as compared with 0-76 1./M.2 obtained 4 minutes after the administration of the drug (Fig. 3) .
Mean Circulation Time: This parameter was measured in 7 patients. The changes observed after the administration of the drug were not significant. The average mean circulation time for the control figure was 21 sec. as compared with 19 sec. recorded 4 minutes after the administration of the drug (Fig. 4) .
Mean Brachial Artery Pressure: The average mean brachial artery pressure decreased from a control of 105 mm. Hg to 70 mm. Hg (34% decrease) observed 6 minutes after the administration of nitroglycerin. The mean of the difference was 15±2 mm. Hg (p<005) (Fig. 3 ). msec. as compared with 293 msec. for the P-R interval of 1 to 300 msec. With an increase in the P-R interval to a range of 301 to 500 msec. the ejection time decreased to 275 msec. Nitroglycerin resulted in a progressive decrease in the ejection time for all ranges of the P-R interval ( , and first derivative of brachial artery pressure (dp/dt) in the groups with fixed and variable heart rate.
variations in the systolic and diastolic pressures occurred in all patients as a function of the P-R interval. The higher figures were obtained when atrial systole occurred in the range of 1 to 300 msec. from ventricular systole. Administration of nitroglycerin resulted in a uniform decrease in the systolic and diastolic pressures for any given range of the P-R interval (Fig. 5 and 6) with a mean difference of the systolic pressure before and after nitroglycerin of 34+8 mm. Hg (p>0.001)
for the P-R interval of 1 to 300 msec. The mean difference of the diastolic pressure before and after nitroglycerin was 6d1 mm. Hg (p<0.05) for the P-R interval of 1 to 300 msec. dp/dt: The first derivative of the brachial artery pressure showed variations in the control figures related to the P-R interval. When atrial systole occurred during ventricular systole the dp/dt was 708 mm. Hg/sec. This parameter rose to 843 mm. Hg/sec. (19% increase) for the P-R interval of 301 to 500 msec. Nitroglycerin resulted in a progressive decrease in the dp/dt for all ranges of the P-R interval ( Fig. 5 and 7 ). Ten minutes after the administration of the drug the dp/dt was 437 mm.
Hg/sec. (43%o decrease) for atrial systole occurring during ventricular systole, 549 mm. Hg/sec. (22% decrease) for the P-R interval of 1 to 300 msec., and 621 mm. Hg/sec. (26% decrease) for the P-R interval of 301 to 500 msec.
Tension-time Index: The tension-time index in the control figures averaged 2664 mm. Hg sec./ min. when atrial systole occurred during ventricular systole, 3143 mm. Hg sec./min. for the P-R interval of I to 300 msec, and 2900 mm. Hg sec./min. for the P-R interval of 301 to 500 msec. Nitroglycerin resulted in a uniform decrease in the tension-time index (30% for the PS, 31% for the P-R interval of 1 to 300 msec., and 28% for the P-R interval of 301 to 500 msec. (Fig. 7) .
Mean Systolic Ejection Rate: Nitroglycerin did-not produce any significant changes in this parameter (Fig. 7) .
Isometric Group 2. Nine patients with normal sinus rhythm were studied. There was no significant difference within this group between patients with heart disease as compared with patients without heart disease. Therefore, this group will be discussed as a whole.
Cardiac Index: The cardiac index did not change significantly after the administration of nitroglycerin (Fig. 2) . The control figure was 2-84 l./min./m.2 as compared with 2-85 L./min/m.2 four minutes after the administration of the drug. The mean difference before and after nitroglycerin was 0-054-0 14 l./min./m.2 (p<0-05). Stroke Index: The stroke index did not change significantly after the administration of nitroglycerin, being 34 ml./beat/m.2 in the control figure and 33 ml./beat/m.2 four minutes after the administration of the drug (Fig. 2) (Fig. 6) . The mean systolic ejection rate (M.S.E.R.), and first derivadifference before and after nitroglycerin was tive of brachial artery pressure (dp/dt) as a function of the P-R interval in the group with complete 12±2 msec. (p> 0.001). heart block before and 2 and 10 minutes after Heart Rate: There was a variable response in nitroglycerin. PS=P wave occurring during venthe heart rate. The resting rate was 82 beats/ tricular systole. min. as compared with 87 beats/min. (6% increase) obtained six minutes after the administration of the drug (Fig. 2) . The mean difference before and after nitroglycerin was 4±2 beats/min. (p<0 05).
Tension-time Index: The tension-time index fell from a control of 2726 mm. Hg sec./min. to 2428 mm. Hg sec./min. (11% decrease) 10 minutes after the administration of nitroglycerin (Fig. 4) . The mean difference before and after nitroglycerin was 270±37 mm. Hg sec./min. (p>0001).
Ventricular Power: The average ventricular power was 4 62 kg. m./min./m2 and it fell to 3 86 kg. m./min./m.2 (17% decrease) 10 minutes after the administration of nitroglycerin (Fig. 3) . The mean difference before and after nitroglycerin was 0-30±0-3 kg. m./min./m.2 (p<0o05).
Stroke Power: The average stroke power at rest was 188 g. m./sec./m.2 and decreased to 141 g. m./sec./m.2 (25% decrease) 10 minutes after the administration of nitroglycerin (Fig. 1) . dp/dt: The first derivative of the brachial artery pressure fell from a control of 770 mm. Hg/sec. (12% decrease) obtained 6 minutes after the administration of nitroglycerin (Fig. 4) .
DIscussIoN
Previous reports have indicated a variable effect of nitroglycerin on coronary flow, ventricular work, and myocardial efficiency in man and in experimental animals (Cameron, 1911; Katz et al., 1938; Essex et al., 1940; Wegria et al., 1951; Brandt, Caccese, and Dock, 1952; Eldridge et al., 1955; Muller and R0rvik, 1958; Sarnoff, Case, and Macruz, 1958b; Brachfeld, Bozer, and Gorlin, 1959; Gorlin et al., 1959; Russek, Urbach, and Zohman, 1955; Gregg, 1950; Case and Roven, 1963; Johnson, Fairley, and Carter, 1959; Honig, Tenney, and Gabel, 1960; Bergamaschi and Glasser, 1963) . Discrepancies are due, in part, to the fact that this drug affects cardiovascular function in a rapid manner and, therefore, measurements of the various parameters need to be performed at very frequent intervals. Determination of blood flow and other values cannot be obtained adequately 90fv7 group.bmj.com on July 7, 2017 -Published by http://heart.bmj.com/ Downloaded from with techniques that require a prolonged steady state. With the introduction of the indicatordilution technique to measure cardiac output, the possibility of rapid determinations of the cardiac output in man became possible (Benchimol, Li, and Dimond, 1964b) . In this present study rapidly repeated measurements of the cardiac functions were obtained before and after the administration of sublingual nitroglycerin.
Our findings indicate that nitroglycerin does not significantly alter the cardiac output and stroke volume in patients with sinus rhythm nor in patients in whom the ventricular rate was maintained fixed with the use of a cardiac pacemaker.
Honig et al. (1960) found that in normal dogs cardiac output increased 10 to 55 per cent after the administration of nitroglycerin and that this effect was observed during the maximal decrease in the diastolic pressure. They concluded that nitroglycerin relieved ischemia by enhancing oxygen delivery rather than by altering load. Our observations demonstrated that despite a significant decrease in the systemic pressure the cardiac output did not change significantly after the administration of the drug to either the group with the fixed or the variable heart rate. It is conceivable that the increase in the cardiac output reported by others may have resulted from an increase in heart rate. The lack of change in the cardiac output was also reported by Brachfeld et al. (1959) in patients without coronary disease and with a normal sinus rhythm. Gorlin et al. (1959) showed a striking decrease in left ventricular work after nitroglycerin, and this was interpreted as the effect of nitroglycerin on circulatory functions via the myocardium as well as via the peripheral vessels.
Bing et at. (1949) postulated that nitroglycerin might exert its beneficial action in angina pectoris by relieving accompanying failure. In support of this view, Johnson et al. (1959) and Muller and R0rvik (1958) demonstrated that nitroglycerin decreased the raised left ventricular end-diastolic pressure found during anginal attack. We have also confirmed the fact that the left ventricular enddiastolic pressure is raised in patients with ischaemic heart disease, and that nitroglycerin decreases this pressure and prevents its rise during exercise (Fig. 8) Dimond and Benchimol, 1963) .
Whether creased ventricular distensibility is not known at the present time. Bing et al. (1949) suggested that this drug might exert its effects by reduction of myocardial oxygen requirements and by a venous pooling effect. Williams and Glick (1964) demonstrated recently that nitroglycerin reduced ventricular dimension in man free of coronary disease. In view of the relation between ventricular dimension and myocardial oxygen consumption, they concluded that this drug favourably influenced the balance between oxygen availability and oxygen requirements which could in part explain the beneficial effect of this drug in relieving angina pectoris. These observations appear to correlate well with the conclusions of Weiss and Ellis (1933) and Brandt et al. (1952) who demonstrated that nitroglycerin decreased heart volume and stroke volume in dogs. Sarnoff et al. (1958b) showed in isolated dog hearts with fixed work and heart rate that nitroglycerin acted as a "pure dilator" with decreased arteriovenous oxygen extraction as coronary flow increased.
In another study, Sarnoff et al. (1958a) demonstrated the primary determinant of myocardial oxygen utilization to be the total tension developed by the myocardium, which was termed the tension-time index. For a given increase in work, oxygen utilization was greater when this increment was induced by increasing pressure (cardiac output constant) than it was when the increment was induced-by increasing cardiac output (pressure constant). Thus, one might conclude that "pressure costs more oxygen than flow".
Our data indicate that nitroglycerin induces a significant decrease in the average ventricular and stroke powers and peripheral resistance in patients with fixed ventricular rate in the absence ofchanges in the cardiac output. Therefore, these findings appear to support the theory that this drug produces its main cardiovascular effect on the peripheral circulation, and, in so doing, reduces work requirements of the myocardium. The reported increase in the coronary flow in the experimental animals and in humans appears to represent the result of coronary artery dilatation which is part of the general effect of the drug, but not necessarily the primary reason for its salutary effect.
In patients with heart block, nitroglycerin resulted in a progressive decrease in ejection time, brachial artery pressure, dp/dt, and tension-time index for any given range of the P-R interval. However, the contribution of atrial systole to the increase in these parameters continues to be present and to the same extent as observed before administration of the drug.
SUMMARY AND CONCLUSIONS
The cardiovascular effects of nitroglycerin were studied in 14 patients with complete heart block and fixed ventricular rate and in 9 patients with normal sinus mechanism.
In patients with complete heart block nitroglycerin did not change the cardiac index, stroke index, and mean circulation time. However, it induced a 34, 15, 21, and 13 per cent decrease in the mean brachial artery pressure, peripheral resistance, average ventricular power, and stroke power, respectively.
Analysis of beat-to-beat variation in relation to the P-R interval was made for the values of the ejection time, brachial artery pressure, tension-time index, first derivative of the brachial artery pressure, and mean systolic ejection rate before and after administration of nitroglycerin. When the P wave occurred during ventricular systole, nitroglycerin induced 8, 24, 43, and 26 per cent decreases in ejection time, brachial artery systolic pressure, first derivative of the brachial artery pressure, and tension-time index, respectively. It did not significantly change the values for the mean systolic ejection rate and isometric contraction time.
Nitroglycerin also resulted in 5, 14, 22, and 20 per cent decreases in ejection time, brachial artery systolic pressure, first derivative of the brachial artery pressure, and tension-time index, respectively, for the P-R interval of 1 to 300 msec.
In patients with sinus mechanism nitroglycerin induced 8, 6, 11, 17, 25, 12, and 11 per cent decreases in the mean arterial pressure, ejection time, tension-time index, ventricular power, stroke power, dp/dt, and peripheral resistance, respectively. Cardiac index and stroke index did not change significantly. The heart rate increased by only 6 per cent. 
